Study: One-Fifth of Neurologists Are Unaware of Epilepsy Drug Risks

John Hopkins researchers have found that 20 percent of neurologists in the United States seem unaware of the serious drug safety risks posed by the use of various anti-epilepsy drugs. The study suggests that the Food and Drug Administration (FDA) should better communicate information about newly-surfaced risks. “Unless it’s a major change requiring the FDA to issue a black box warning on a product, important information appears to be slipping through the cracks. We need a more systematic and comprehensive method so that doctors receive updated safety warnings in a format that guarantees they will see and digest what they need to protect patients,” the study’s lead investigator said. Click here to read the full story.